PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease. - Wikidata - thesis-toulmin - TriplyDB

PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.

PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.

http://www.wikidata.org/entity/Q34025404

about

The MicroRNA-21 in Autoimmune Diseases Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types Differential processing of small RNAs during endoplasmic reticulum stress.YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research.Sequence features of Drosha and Dicer cleavage sites affect the complexity of isomiRs Dumbbell-PCR: a method to quantify specific small RNA variants with a single nucleotide resolution at terminal sequences Genetic determinants of fibro-osseous lesions in aged inbred mice.Overview of microRNA biology.Identification of factors involved in target RNA-directed microRNA degradation.RNA-Sequencing Analysis of Messenger RNA/MicroRNA in a Rabbit Aneurysm Model Identifies Pathways and Genes of Interest.Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles.HER2-encoded mir-4728 forms a receptor-independent circuit with miR-21-5p through the non-canonical poly(A) polymerase PAPD5.Uridylation and adenylation of RNAs.A feedback mechanism between PLD and deadenylase PARN for the shortening of eukaryotic poly(A) mRNA tails that is deregulated in cancer cells.The role of microRNAs in autoimmune diseases with skin involvement.miRNAs in inflammatory skin diseases and their clinical implications.Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease.microRNAs in Psoriasis.Significant role for microRNA-21 affecting toll-like receptor pathway in primary graft dysfunction after human lung transplantation.The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice.MicroRNA Regulation of Oxidative Stress-Induced Cellular Senescence Gld2-catalyzed 3' monoadenylation of miRNAs in the hippocampus has no detectable effect on their stability or on animal behavior.Association of microRNAs with Argonaute proteins in the malaria mosquito Anopheles gambiae after blood ingestion Naturally existing isoforms of miR-222 have distinct functions.Alpha-1 antitrypsin augmentation therapy decreases miR-199a-5p, miR-598 and miR-320a expression in monocytes via inhibition of NFκB.Function Control of Anti-microRNA Oligonucleotides Using Interstrand Cross-Linked Duplexes.Diurnal Oscillations in Liver Mass and Cell Size Accompany Ribosome Assembly Cycles.The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer.How miRs and mRNA deadenylases could post-transcriptionally regulate expression of tumor-promoting protein PLD.Loss of the RNA helicase SKIV2L2 impairs mitotic progression and replication-dependent histone mRNA turnover in murine cell lines.A Comprehensive Approach to Sequence-oriented IsomiR annotation (CASMIR): demonstration with IsomiR profiling in colorectal neoplasia.Functional Interplay between Small Non-Coding RNAs and RNA Modification in the Brain.Understanding psoriasis: Role of miRNAs Target RNAs Strike Back on MicroRNAs

P2860

0ffacd98beb5875e55b2fd78bfb007b99552dd8f e2ab37f6bde8b15c1056c74322d78802b724c3a0

P248

Q26748427-042167B0-2E33-4961-9D6C-28CF3E6765FC Q33557718-B297EB66-98F3-41E5-83A7-B71B4CA9D622 Q33612455-C324AC4E-CAE0-430B-893C-B0CCE94093FD Q35254030-F2164695-D922-467B-B40E-F140A5F62E3A Q35585617-4BCAF0B4-05A0-4FEB-8BCC-ED45F6B067D8 Q35842454-0AE7616A-8F95-4003-91A4-DFEAB8295493 Q36616878-72C0ABED-8781-4104-9100-3E8EBA0374B2 Q36702371-A7273C6F-C79F-4F4A-B42E-FAC0C720730A Q36775554-31875EC1-5B53-4266-A36C-B8ED8380385C Q37046193-F966B077-A601-4C12-914D-929687041D19 Q37225603-F2DE1AE4-5AAC-4B75-AAD6-9AEAB2358282 Q37345945-CDFD2F46-DC2B-4C7D-88BE-F77B499824B8 Q37385261-511B1503-D0A9-4872-8063-E8920D6DC07B Q37644513-0317A4FA-D550-46AF-A5C3-588F445B2DE2 Q38272151-0989FDA8-A87A-4744-BDA4-439E1702E05D Q38365504-98388F62-EFBB-4AD3-9564-64551C9B76AD Q38411937-8F65F15D-DAF3-4853-B282-42B606385F30 Q38708656-49E99DF5-6D01-4685-871E-9B52B88E06F6 Q38738172-91206E37-D876-44AA-B51C-A01CB9402393 Q38744451-74E5F404-24AF-4748-8902-A35414312FD5 Q39358659-853B1979-57CA-4288-B106-ED2B88531CE3 Q39519691-52A74257-F9CF-46E9-B437-E21ECB4736A4 Q41139985-4355F82D-C68E-4EAC-9888-BA6AA87B3AAC Q41990770-59FC13A2-3B00-4942-94F3-2216E3392BE7 Q42924805-D8AE60D4-1171-4983-AD55-1FDA21674D49 Q47096791-38B1AFCA-5550-4433-9482-4A8415C58BAA Q47215525-C28C4B86-A412-420A-833B-581D8AB05E2C Q47652779-1A339FAD-B283-44BC-BD03-FB18A42D20FF Q47721202-0CB76846-963B-4769-AAD8-619B260894FD Q51082530-852DE9F5-0273-4811-BDEB-AB40DB1B0D59 Q55365069-1AE626D9-EC3A-47FE-83F7-4E6F9ED1CFE9 Q55668403-6B33C876-8994-42C2-8548-B29997606BFC Q58544217-6CE2E868-2ECC-42E1-B216-0DDF0C455D97 Q58586289-2CF5EFD3-9BA8-47F7-8088-C718489C7B75

P2860

PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.

http://www.wikidata.org/entity/Q34025404

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

PAPD5-mediated 3' adenylation ...... pted in proliferative disease.

@ast

PAPD5-mediated 3' adenylation ...... pted in proliferative disease.

@en

PAPD5-mediated 3' adenylation ...... pted in proliferative disease.

@nl

type

label

PAPD5-mediated 3' adenylation ...... pted in proliferative disease.

@ast

PAPD5-mediated 3' adenylation ...... pted in proliferative disease.

@en

PAPD5-mediated 3' adenylation ...... pted in proliferative disease.

@nl

prefLabel

PAPD5-mediated 3' adenylation ...... pted in proliferative disease.

@ast

PAPD5-mediated 3' adenylation ...... pted in proliferative disease.

@en

PAPD5-mediated 3' adenylation ...... pted in proliferative disease.

@nl

P1433

Q34025404-75AA6BA0-27A6-459E-A2AA-91D1BEDB9C1C

P1476

Q34025404-DA09559E-5AAF-400A-A762-99FF0C0055ED

P2093

Q34025404-1A90E717-502F-470D-A7BA-BAF1FBE1BEB6

Q34025404-229115B3-85AB-4ACF-8F5C-61BDA1B19717

Q34025404-29A4C14A-2BDC-4B02-B781-2707920C0B28

Q34025404-3362C1BE-2FEA-4EEB-8D25-FDDEF674A8BE

Q34025404-36F4F4B0-1026-4C27-A038-2CE007371AFA

Q34025404-62A7E5DA-1738-43B9-BE11-D3FF5F0E6CDC

Q34025404-66A3BED4-AABB-4C8E-BDF8-114CC15148D7

Q34025404-690ABCB1-2047-48C3-83AF-1651BFB93CD7

Q34025404-69F0CCA0-DEC3-4FD4-B314-97135684CC9B

Q34025404-7A768DD9-CC23-46FB-A73F-976A2423C43B

P2860

Q34025404-039ED1A6-00D3-463E-85CB-4335EAC73AD9

Q34025404-03F13D37-17CA-4A7D-B738-FA549AF351CC

Q34025404-0C379D67-EC87-4871-9D01-D15D1496C2DC

Q34025404-0C4BE8B8-2208-45FD-859E-FA3B16362F5E

Q34025404-0D1B4E26-2FA2-4E4B-A093-E0CA910AE5BC

Q34025404-10786350-22CE-4538-BFD3-69DA78266F7D

Q34025404-11707A7C-D513-4BA2-83F9-FA2FDF456B23

Q34025404-18D00F7C-1C0E-4BFF-8FE6-433C694F6C58

Q34025404-1A9FFDA4-92E8-4F65-AEF9-9F83059F3CF8

Q34025404-226756B2-DB62-4D6B-8599-5D187EBCE24D

P304

Q34025404-B1BABAAA-00AE-41BB-86E5-EFC0172E63B7

P31

Q34025404-F8F1DF31-5B31-4ABC-A8FF-6734B0C7D4C4

P356

Q34025404-BC7B1537-5FBC-40B2-B18E-A06AA06E9776

P407

Q34025404-3D2BBC2B-B86A-4A95-A056-68D3C0C900AD

P433

Q34025404-061DF476-289D-4DD1-A60A-072C62BCB82F

P478

Q34025404-0E72B267-0408-42CD-988C-53E49A08F7FE

P50

Q34025404-194E65CF-7950-4CEE-A3FB-00EECDD66D0D

Q34025404-4E0AFEA1-EB22-40AA-A32E-DB187446A47E

Q34025404-8C6C2A97-65F6-4500-8D01-6E3F6CF6AC84

Q34025404-97007A4B-F7FB-45D1-88DE-8717231705A1

Q34025404-A63BDBB1-9573-458C-B6D4-922705DB4FB2

Q34025404-A6BB83E8-F7BB-49E6-A57A-3007275A820F

Q34025404-A7AF4782-0A3D-4929-BA0E-E2E2E1DE028E

Q34025404-BD4AAF26-2B0F-4283-83C6-C6F806801BDF

P577

Q34025404-19BAB9AC-BC69-4F2F-BAE0-6C83F93B0845

P5875

Q34025404-0C65A224-B4B8-4111-977D-7D7C2F5999CD

P698

Q34025404-6DA8C28F-35E1-40FE-A6B0-E93703AFE591

P921

Q34025404-1C3AC4FD-A5E2-4C5C-BF20-3115673C0AAA

Q34025404-58CBD6AF-E5F5-4672-A541-4C31BC93DB6E

Q34025404-915AD632-5E87-4C81-BB6F-CA8D87762A2E

P932

Q34025404-88FAA1C4-D69A-4D3A-9FD1-65C6E3FF7136

P356

PNAS.1317751111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

PAPD5-mediated 3' adenylation ...... upted in proliferative disease

@en

P2093

A Maxwell Burroughs

http://www.w3.org/2001/XMLSchema#string

Akira Hasegawa

http://www.w3.org/2001/XMLSchema#string

Ayumi Ogawa

http://www.w3.org/2001/XMLSchema#string

Carlos Rovira

http://www.w3.org/2001/XMLSchema#string

Chihiro Sasaki

http://www.w3.org/2001/XMLSchema#string

Chizuru Suzuki

http://www.w3.org/2001/XMLSchema#string

Cristian Coarfa

http://www.w3.org/2001/XMLSchema#string

Harukazu Suzuki

http://www.w3.org/2001/XMLSchema#string

Jay W Shin

http://www.w3.org/2001/XMLSchema#string

Kaoru Kaida

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

The nuclear RNase III Drosha initiates microRNA processing

TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation

Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA

The Microprocessor complex mediates the genesis of microRNAs

Mfold web server for nucleic acid folding and hybridization prediction

Selective blockade of microRNA processing by Lin28

Psoriasis genetics: breaking the barrier

Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP

A mammalian microRNA expression atlas based on small RNA library sequencing

P304

11467-11472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1317751111

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Shannon M. Hawkins

P577

2014-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264125968

http://www.w3.org/2001/XMLSchema#string

P698

25049417

http://www.w3.org/2001/XMLSchema#string

P921

Poly(A)-specific ribonuclease

Terminal nucleotidyltransferase 4B

ncRNA polyadenylation

P932

4128123

http://www.w3.org/2001/XMLSchema#string